Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_815_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Series Editors’ preface
- •Editors’ preface
- •Evidence-based practice in surgery
- •Contributors
- •Liver function and failure
- •Hepatic, biliary and pancreatic anatomy
- •Staging and assessment of hepatobiliary malignancies
- •Benign liver lesions
- •Primary malignant tumours of the liver
- •Colorectal liver metastases
- •Non-colorectal hepatic metastases
- •Portal hypertension and liver transplantation
- •Pancreas and islet transplantation
- •The spleen and adrenal glands
- •Gallstones
- •Benign biliary tract diseases
- •Malignant lesions of the biliary tract
- •Complicated acute pancreatitis
- •Chronic pancreatitis
- •Pancreatic adenocarcinoma
- •Cystic and neuroendocrine tumours of the pancreas
- •Hepatobiliary and pancreatic trauma


Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

A Companion to Specialist Surgical Practice
Series Editors
O. James Garden
Simon Paterson-Brown
HEPATOBILIARY AND
PANCREATIC SURGERY
SIXTH EDITION
Edited by
Rowan W. Parks
MBBCh BAO MD FRCSI FRCS(Ed)
Professor of Surgical Sciences, Clinical Surgery, The University of Edinburgh;
Honorary Consultant HPB Surgeon, Royal Infirmary of Edinburgh, Edinburgh, UK
For additional online content visit ExpertConsult.com
Edinburgh London New York Oxford Philadelphia St Louis Sydney 2019
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

© 2019, Elsevier Limited. All rights reserved.
First edition 1997
Second edition 2001
Third edition 2005
Fourth edition 2009
Fifth edition 2014
Sixth edition 2019
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical,
including photocopying, recording, or any information storage and retrieval system, without permission in writing from
the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our
arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be
found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as
may be noted herein).
Notice
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any
information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences,
in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law,
no responsibility is assumed by Elsevier, authors, editors or contributors for any injury and/or damage to persons
or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
ISBN: 978-0-7020-7250-5
Printed in China
Last digit is the print number: 9 8 7 6 5 4 3 2 1
Content Strategist: Laurence Hunter
Content Development Specialist: Lynn Watt
Project Manager: Umarani Natarajan
Design: Miles Hitchen
Illustration Manager: Nichole Beard
Illustrator: MPS North America LLC
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

Series Editors’ preface
The Companion to Specialist Surgical Practice series
has now come of age. This Sixth Edition takes the
series to a different level since it was first published
in 1997. The intention from the outset was to ensure
that we could support the educational needs of those
in the later years of specialist surgical training and
of consultant surgeons in independent practice who
wished for contemporary, evidence-based information
on the subspecialist areas relevant to their general
surgical practice. Although there still seems to be a
role for larger reference surgical textbooks, and having
contributed to many of these, we appreciate that it is
difficult for them to keep pace with changing surgical
practice.
This Sixth Edition continues to keep abreast of the
increasing specialisation in general surgery. The rise
of minimal access surgery and therapy, and the desire
of some subspecialities, such as breast and vascular
surgery, to separate away from 'general surgery' may
have proved challenging in some countries. However,
they also underline the importance for all surgeons of
being aware of current developments in their surgical
field. This series as a consequence continues to place
emphasis on the need for surgeons to deliver a highquality emergency surgical practice. The importance
of evidence-based practice remains throughout,
and authors have provided recommendations and
highlighted key resources within each chapter. The
ebook version of the textbook has also enabled
improved access to the reference abstracts and links
to video content relevant to many of the chapters.
We have recognised in this Sixth Edition that
new blood is required to maintain the vitality of
content. We are indebted to the volume editors, and
contributors, who have stood down since the last
edition and welcome the new leadership on several
volumes. The contents have been comprehensively
updated by our contributors and editorial team. We
remain grateful for the support and encouragement
of Laurence Hunter and Lynn Watt at Elsevier.
We trust that our original vision of delivering
an up-to-date affordable text has been met and
that readers, whether in training or independent
practice, will find this Sixth Edition an invaluable
resource.
O. James Garden, CBE, BSc, MBChB, MD, FRCS
(Glas), FRCS(Ed), FRCP(Ed), FRACS(Hon), FRCSC
(Hon), FACS(Hon), FCSHK(Hon), FRCSI(Hon),
FRCS(Engl)(Hon), FRSE
Regius Professor of Clinical Surgery, Clinical
Surgery, The University of Edinburgh and Honorary
Consultant Surgeon, Royal Infirmary of Edinburgh,
Edinburgh, UK
Simon Paterson-Brown, MBBS, MPhil, MS,
FRCS(Ed), FRCS(Engl), FCSHK, FFST(RCSEd)
Honorary Clinical Senior Lecturer, Clinical Surgery,
The University of Edinburgh and Consultant
General and Upper Gastrointestinal Surgeon, Royal
Infirmary of Edinburgh, Edinburgh, UK
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
v

Editors’ preface
The Sixth Edition of Hepatobiliary and Pancreatic
Surgery builds on the strong foundation provided by
my colleague Professor James Garden, who edited
the previous five editions and kindly invited me to
join him as co-editor for the Fifth Edition. Over the
past 20 years, this volume and, indeed, the entire
Companion to Specialist Surgical Practice series,
has become well established with a remarkable
reputation. It is a privilege to be able to build on
this legacy.
Each new edition brings the opportunity to update
and refresh the content and format of the book. For
this Sixth Edition, half of the chapters have been
delivered by new contributors and, in particular,
there is a new section on liver transplantation
and an entirely new chapter on pancreas and islet
transplantation.
The aim has been to secure further leading
international experts to ensure contemporary,
evidence-based content on the various aspects of
benign and malignant liver, biliary and pancreatic
disease. All chapters have been brought up to date
with new content highlighting current guidelines
and practice, with high-quality images, figures and
video content to enhance the resources available
to the reader.
Acknowledgements
I am indebted to the input of all previous editions’
contributors and, as in selected areas some of the
core content has been retained. I would especially
like to acknowledge Steven Strasberg, Jean-Francois
Gigot, Rene Adam, Graham Poston, Geoffrey
Haydon, John Isaac, John Buckels, Simon Olliff,
Richard Schlinkert, Leslie Nathanson, Murat Akyol
and Jacob Izbicki. I am grateful to colleagues at
Elsevier, particularly Laurence Hunter and Lynn
Watt, for their guidance and encouragement during
this project and for trying to keep progress on
schedule. I would also wish to acknowledge the
tremendous support and tolerance of my wife,
Janet, and my children, Matthew, Amy, Naomi and
Thomas, in allowing me to deliver this volume.
Rowan W. Parks
Edinburgh
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
vii

Evidence-based practice in surgery
Critical appraisal for developing evidence-based
practice can be obtained from a number of sources,
the most reliable being randomised controlled
clinical trials, systematic literature reviews, metaanalyses and observational studies. For practical
purposes three grades of evidence can be used,
analogous to the levels of ‘proof’ required in a court
of law:
1. Beyond all reasonable doubt. Such evidence
is likely to have arisen from high-quality
randomised controlled trials, systematic reviews
or high-quality synthesised evidence such as
decision analysis, cost-effectiveness analysis or
large observational datasets. The studies need
to be directly applicable to the population of
concern and have clear results. The grade is
analogous to burden of proof within a criminal
court and may be thought of as corresponding
to the usual standard of ‘proof’ within the
medical literature (i.e. P <0.05).
2. On the balance of probabilities. In many cases
a high-quality review of literature may fail to
reach firm conclusions due to conflicting or
inconclusive results, trials of poor methodological
quality or the lack of evidence in the population
to which the guidelines apply. In such cases
it may still be possible to make a statement
as to the best treatment on the ‘balance of
probabilities’. This is analogous to the decision in
a civil court where all the available evidence will
be weighed up and the verdict will depend upon
the balance of probabilities.
3. Not proven. Insufficient evidence upon which to
base a decision, or contradictory evidence.
Depending on the information available, three
grades of recommendation can be used:
a. Strong recommendation, which should be
followed unless there are compelling reasons to
act otherwise.
b. A recommendation based on evidence of
effectiveness, but where there may be other
factors to take into account in decisionmaking, for example the user of the guidelines
may be expected to take into account patient
preferences, local facilities, local audit results or
available resources.
c. A recommendation made where there is no
adequate evidence as to the most effective
practice, although there may be reasons for
making a recommendation in order to minimise
cost or reduce the chance of error through a
locally agreed protocol.
Evidence where a conclusion can be reached
‘beyond all reasonable doubt’ and therefore
where a strong recommendation can be given.
This will normally be based on evidence levels:
• Ia. Meta-analysis of randomised controlled trials
• Ib. Evidence from at least one randomised
controlled trial
• IIa. Evidence from at least one controlled study
without randomisation
• IIb. Evidence from at least one other type of quasi-
experimental study.
Evidence where a conclusion might be reached
‘on the balance of probabilities’ and where there
may be other factors involved which influence the
recommendation given. This will normally be based
on less conclusive evidence than that represented
by the double tick icons:
• III. Evidence from non-experimental descriptive
studies, such as comparative studies and case–
control studies
• IV. Evidence from expert committee reports or
opinions or clinical experience of respected
authorities, or both.
Evidence that is associated with either a strong
recommendation or expert opinion is highlighted in
the text in panels such as those shown above, and is
distinguished by either a double or single tick icon,
respectively. The references associated with doubletick evidence are listed as Key References at the
end of each chapter, along with a short summary of
the paper's conclusions where applicable. The full
reference list for each chapter is available in the ebook.
The reader is referred to Chapter 1, ‘Evaluation
of surgical evidence’ in the volume Core Topics in
General and Emergency Surgery of this series, for a
more detailed description of this topic.
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
ix

Contributors
Ian J. Beckingham, DM, FRCS
Department of Surgery, Queens Medical Centre,
Nottingham, UK
Adam Brooks, MBA, MBChB, FRCS
Consultant HPB Surgeon and Director, East
Midlands Major Trauma Centre, Nottingham
University Hospital NHS Trust, Nottingham, UK
Olivier R.C. Busch, MD, PhD
Gastrointestinal Surgeon, Department
of Surgery, Academic Medical Center, Amsterdam,
The Netherlands
C. Ross Carter, MD, FRCS
West of Scotland Pancreatic Unit, Glasgow Royal
Infirmary, Glasgow, UK
John Casey, PhD, MBChB, PhD, FRCS(Glasg),
FRCS(Ed), FRCS(Gen Surg), FRCP Edin
Consultant Surgeon/Hon Senior Lecturer,
Lead Clinician for Transplantation in Scotland,
Lead Clinician for National Islet Transplant
Programme, Chair NHSBT UK Pancreas
Advistory Group, Transplant Unit, Royal Infirmary
of Edinburgh, Edinburgh, UK
Steve M.M. de Castro, PhD, MD
Department of Surgery, OLVG, Amsterdam,
The Netherlands
Kevin C. Conlon, MBMCh, FRCSI, FRCSEd,
FRCSGlas, FACS, MBA, MA, FTCD
Professor and Academic Head, Department
of Surgery, Trinity College Dublin; Consultant
Hepatobiliary Surgeon, Department of HPB
Surgery, St Vincent’s University Hospital,
Dublin, Ireland
Cornelis H.C. Dejong, MD, PhD, FRCSED, FEBS
Professor of HPB Surgery, Department of Surgery,
European Surgical Centre Aachen-Maastricht
(ESCAM), Maastricht University Medical Centre,
Maastricht, The Netherlands; Universitätsklinikum
Aachen, Aachen, Germany
Euan J. Dickson, MBChB, MD, FRCS
Consultant Surgeon, West of Scotland Pancreatic
Unit, Glasgow Royal Infirmary, Glasgow, UK
Mary E. Dillhoff, MD, MS
Assistant Professor of Surgery, Department of
Surgery, The Ohio State University Wexner Medical
Center, Columbus, OH, USA
Marcel den Dulk, MD, PhD, FRCS
Consultant HPB and Pediatric Surgeon, Department
of Surgery, European Surgical Centre AachenMaastricht (ESCAM), Maastricht University Medical
Centre, Maastricht, The Netherlands;
Universitätsklinikum Aachen, Aachen, Germany
Olivier Farges, MD, PhD
Department of Surgery, Hôpital Beaujon,
Assistance Publique-Hôpitaux de Paris, University
Paris, Clichy, France
Stephen W. Fenwick, BMedSci, BMBS,
MD, FRCS
Consultant Hepatobiliary Surgeon, Department of
Hepatobiliary Surgery, Aintree University Hospital,
Liverpool, UK
Steven Gallinger, MD, MSc, FRCSC
Professor of Surgery, Division of General Surgery
Toronto General Hospital, University Health Network,
University of Toronto, Toronto, Canada
Saxon Connor, MBChB, FRACS
HPB Surgeon, Department of Surgery,
Christchurch Hospital, Christchurch,
New Zealand
Otto M. van Delden, MD, PhD
Department of Radiology, Academic Medical Centre,
Amsterdam, The Netherlands
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
O. James Garden, CBE, BSc, MBChB, MD
FRCS(Glas), FRCS(Ed), FRCP(Ed), FRACS(Hon),
FRCSC(Hon), FACS(Hon), FCSHK(Hon),
FRCSI(Hon), FRCSEng(Hon), FRSE
Regius Professor of Clinical Surgery, Clinical
Surgery, The University of Edinburgh and Honorary
Consultant Surgeon, Royal Infirmary of Edinburgh,
Edinburgh, UK
xi

Contributors
William R. Jarnagin, MD
Chief, Hepatopancreatobiliary Service, Benno C.
Schmidt Professor of Surgical Oncology, Memorial
Sloan-Kettering Cancer Center; Professor of
Surgery, Weill Cornell Medical College, New York,
NY, USA
Geoffrey W. Krampitz, MD, PhD
General Surgery Resident, Department of Surgery,
Stanford University School of Medicine, Stanford,
CA, USA
Russell C. Langan, MD
Memorial Sloan Kettering Cancer Center, Surgery,
Surgical Oncology, New York, NY, USA
Chetana Lim, MD, PhD
HPB and Liver Transplantation, Henri Mondor
Hospital, Creteil, France
Shishir K. Maithel, MD, FACS
Associate Professor of Surgery, Division of Surgical
Oncology, Department of Surgery, Emory University,
Winship Cancer Institute, Atlanta, GA, USA
Colin J. McKay, MBChB, MD, FRCS
Consultant Pancreatic Surgeon, West of Scotland
Pancreatic Unit, Glasgow Royal Infirmary,
Glasgow, UK
Carol-anne Moulton, MEd, PhD, FRACS
Associate Professor, Department of Surgery,
University of Toronto, Canada
Alex P. Navarro, MBBS, BMedSci(Hons),
FRCS, PhD
Consultant HPB and Major Trauma Surgeon, Queens
Medical Centre, Nottingham University Hospitals
NHS Trust, Nottingham, UK
Stephen O’Neill, MSc, PhD
Surgical Registrar, HPB and Transplant Surgery,
Royal Infirmary of Edinburgh, Edinburgh, UK
Gabriel C. Oniscu, MD, FRCS
Consultant Transplant Surgeon, Transplant Unit,
Royal Infirmary of Edinburgh; Honorary Clinical Senior
Lecturer, Clinical Surgery, University of Edinburgh,
Edinburgh, UK
Timothy M. Pawlik, MD, MPH, PhD
Professor and Chair, The Urban Meyer III and Shelley
Meyer Chair for Cancer Research; Department of
Surgery, The Ohio State University Wexner Medical
Center, Columbus, OH, USA
Amir A. Rahnemai-Azar, MD
Surgical Oncology Fellow, Department of Surgery,
Division of Surgical Oncology, University of
Wisconsin Hospital, Madison, WI, USA
Shaheel M. Sahebally, MB, MRCS
Department of Hepatobiliary Surgery, St Vincent's
University Hospital, Dublin, Ireland
Carl Schmidt, MD
Associate Professor of Surgery, Department of
Surgery, The Ohio State University Wexner Medical
Center, Columbus, OH, USA
Ajith K. Siriwardena, MD, FRCS
Professor of Hepatobiliary Surgery, Regional HepatoPancreato-Biliary Unit, Manchester Royal Infirmary,
Manchester, UK
Benjamin M. Stutchfield, BSc(Hons), MBChB,
MSc, MRCS(Ed), PhD
Clinical Lecturer and Honorary Surgical Registrar,
University of Edinburgh, Edinburgh, UK
Andrew Sutherland, MBChB, BSc(Hons),
DPhil, FRCSEd
Consultant Surgeon, Transplant Surgery, Royal
Infirmary of Edinburgh, Edinburgh, UK
Benjamin N.J. Thomson, MBBS, DMedSc, FACS,
FRACS
Clinical Associate Professor, The University of
Melbourne; HPB Surgeon & Head of General
Surgical Specialties, The Royal Melbourne Hospital,
Parkville, Victoria, Australia
Brendan Visser, MD
Associate Professor of Surgery, Hepatobiliary and
Pancreatic Surgery, Stanford University School of
Medicine, Stanford, CA, USA
Stephen J. Wigmore, BSc(Hons), MBBS, MD,
FRCSEd, FRCS(Gen Surg), FRCPEd
Professor of Transplantation Surgery, Clinical Surgery,
The University of Edinburgh; Honorary Consultant
Surgeon, Royal Infirmary of Edinburgh, Edinburgh, UK
Vincent S. Yip, MBChB, MD, FRCS
Consultant in HPB Surgery, Department of Surgery,
Royal Liverpool and Broadgreen University Hospital,
Liverpool, UK
Nathan Zilbert, MD, MEd, FRCSC
Hepato-Pancreato-Biliary Surgery Fellow, Department of
Surgery, University of Toronto, Toronto, Ontario Canada
xii
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

1
Liver function and failure
Benjamin M. Stutchfield
Stephen J. Wigmore
Overview of liver functions
and evolution
The liver is the largest solid organ in the human
body. It has a unique structure with a dual blood
supply, being approximately one-third from the
hepatic artery and two-thirds from the portal venous
system. Within the liver substance blood flows
through sinusoids between plates of hepatocytes
to drain into central veins, which in turn join the
hepatic veins draining into the vena cava. The
liver is a major site of protein synthesis exporting
plasma proteins to maintain oncotic pressure and
coagulation factors. Acute phase proteins that act
as antiproteases, opsonins and metal ion carriers
are synthesised by the liver in response to injury or
infection. Numerous immune cells populate the liver
and the resident tissue macrophages, the Kupffer
cells, form an important component of the innate
immune system. Nutrients are extracted from portal
blood by the liver and processed, and the liver acts as
an important reservoir for glycogen. Waste products
are either modified in the liver for excretion by
the kidneys or are excreted into bile. Many drugs
are taken up by the liver and metabolised, giving
either active metabolites or inactive metabolites
for excretion. In humans, as in many vertebrates,
the liver's capacity for metabolism and clearance
far exceeds what is required for day-to-day life.
It is possible that this ability offers a significant
advantage in terms of survival from poisoning,
starvation or trauma.
Symptoms of liver failure:
acute and chronic
In the acute setting, liver failure can present with
a number of symptoms, but it is important to note
that not all of these may be present at the same
time. Typically, a patient with acute liver failure
after surgery, transplantation or due to acute
poisoning will be confused or mentally slow as a
result of encephalopathy, which may progress to
loss of consciousness and a need to protect the
airway by intubation and mechanical ventilation.
Patients are often not immediately jaundiced, but
jaundice may develop over the course of several
days. Patients may be hypoglycaemic and the
requirement for intravenous infusion of dextrose
is a sinister development and an indicator of severe
acute liver failure. Coagulopathy may develop,
with evidence of bruising or bleeding from line
sites or surgical scars. Severe acute liver failure
can be assessed using the King's College Hospital
criteria, which were designed to predict mortality
in paracetamol- and non-paracetamol-dependent
acute liver failure.
adopted in the UK to determine criteria indicating
likely benefit from liver transplantation. In the
surgical patient, the development of acute liver
failure is usually more gradual and less dramatic;
a useful scoring system for liver dysfunction in the
acute setting has been reported by Schindl etal.
(see Box1.1).
1
Later, this scoring system was
2
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
1
Соседние файлы в папке Библиотека им академика М.И. Перельмана
